Part 2/8:
The excitement surrounding CAR-T therapies has faced a sobering reality check. In a discussion between Shannon Jones and Todd Campbell, it was emphasized how pre-launch expectations often tend to be overly optimistic. Despite the complex nature of gene therapies, which carry exorbitant price tags—often exceeding $500,000—all-in costs—even the leading CAR-T products have yet to deliver the blockbuster sales figures anticipated at their inception.